Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 2 5Phase 1/2 4Phase 1 4Phase 4 1

Status

Withdrawn 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1053OTHER 619NIH 108NETWORK 18OTHER_GOV 8FED 4UNKNOWN 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4Breast 4Gastrointestinal 3Gynecologic 2Genitourinary 2CNS 2Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thoracic Neoplasms 1Neoplasms by Site 1Neoplasms 1Lung Diseases 1Carcinoma, Bronchogenic 1

Interventions

pembrolizumab 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × FED × Thoracic × Clear all
NCT05430009 2022-08-01

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

VA Ann Arbor Healthcare System

Phase 1 Recruiting
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02653612 2018-03-02

Intraoperative Imaging of Pulmonary Adenocarcinoma

VA Office of Research and Development

Phase 1 Withdrawn
Thoracic

Lung Neoplasms

NCT01574222 2018-01-18

VTNSCLC

VA Office of Research and Development

Phase 1 Terminated
1 enrolled
Thoracic

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Thoracic Neoplasms

NCT00108186 2014-10-29

Celecoxib Treatment for Lung Cancer

VA Office of Research and Development

Phase 1 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡